Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Dale Jonathan Terasaki

TitleAffiliate - DHHA
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Caprio E, Belfer K, Terasaki D. Exploring the Role of Psychologists on Addiction Consult Services in Acute Care Settings. J Clin Psychol Med Settings. 2025 Apr 26. PMID: 40281325.
      View in: PubMed
    2. Terasaki D. A Critique of Phenobarbital Tapers With Buprenorphine or Methadone Initiations. J Addict Med. 2025 Apr 17. PMID: 40243173.
      View in: PubMed
    3. Calcaterra SL, Terasaki D. When Usual Care Is Subpar Care for Hospitalized Patients With Opioid Use Disorder. JAMA Intern Med. 2025 Apr 07. PMID: 40193083.
      View in: PubMed
    4. Steil L, Terasaki D, Reiss R, Deaney M. Review of acamprosate pharmacokinetics and dosing strategies. Ment Health Clin. 2025 Apr 01; 15(2):56-61. PMID: 40224514.
      View in: PubMed
    5. Terasaki D, Frank JW, Schacht J. Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial. J Addict Med. 2025 Mar-Apr 01; 19(2):236-237. PMID: 39446063.
      View in: PubMed
    6. Terasaki D, Loh R, Simpson S. Two Clinical Insights on Methamphetamine Withdrawal at a Safety-net Hospital. J Addict Med. 2025 Jan-Feb 01; 19(1):118. PMID: 39230516.
      View in: PubMed
    7. Terasaki D. Acute Subjective Experiences of Intravenous Ketamine Therapy Among Medically Hospitalized Patients with Alcohol Use Disorder. Psychedelic Med (New Rochelle). 2024 Jun; 2(2):116-126. PMID: 40051584.
      View in: PubMed
    8. Terasaki D, Abts D, Ferraro K. Questioning methadone split-dosing for analgesia among hospitalized patients with opioid use disorder. Addiction. 2024 Dec; 119(12):2044-2047. PMID: 38615677.
      View in: PubMed
    9. Terasaki D, Ellinwood A, White D. Quadruple pharmacotherapy for alcohol use disorder tolerable yet insufficient: a case report. Subst Abuse Treat Prev Policy. 2024 Feb 29; 19(1):18. PMID: 38424567.
      View in: PubMed
    10. Lyden J, Loh R, Braun H, Terasaki D. Characterizing safer drinking strategies among hospitalized adults with severe alcohol use disorder; a cross-sectional secondary analysis. J Addict Dis. 2024 Oct-Dec; 42(4):551-555. PMID: 37946362.
      View in: PubMed
    11. Terasaki D, Hanratty R, Thurstone C. More than MAT: lesser-known benefits of an inpatient addiction consult service. Hosp Pract (1995). 2023 08; 51(3):107-109. PMID: 37314327.
      View in: PubMed
    12. Deaney M, Terasaki D. Intramuscular, extended-release naltrexone inadvertently administered in the deltoid muscle: A case report. J Am Pharm Assoc (2003). 2023 Jul-Aug; 63(4):1245-1248. PMID: 37207707.
      View in: PubMed
    13. Terasaki D, Kulick B, Calcaterra S, Ray L. Phenobarbital for alcohol withdrawal in the context of the opioid epidemic: a neglected caveat. Addiction. 2023 07; 118(7):1198-1200. PMID: 36967706.
      View in: PubMed
    14. Terasaki D. Self-reported Past Experiences With Naltrexone and Attitudes Toward Daily Adherence Among High-utilization Patients With Alcohol Use Disorder. J Addict Med. 2023 May-Jun 01; 17(3):371-372. PMID: 37267196.
      View in: PubMed
    15. Terasaki D, Loh R, Cornell A, Taub J, Thurstone C. Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates. Addict Sci Clin Pract. 2022 11 22; 17(1):64. PMID: 36419181.
      View in: PubMed
    16. Terasaki D, Brady J. Severe, Nondelirium Agitation as an Underreported Characteristic of Precipitated Fentanyl Withdrawal: A Case Report. J Addict Med. 2023 Jan-Feb 01; 17(1):111-113. PMID: 35914120.
      View in: PubMed
    17. Terasaki D. Cardiovascular medications on discharge for patients with chest pain and concurrent cocaine use. Am J Emerg Med. 2022 08; 58:315-316. PMID: 35279327.
      View in: PubMed
    18. Mortaji P, Terasaki D, Moo-Young J. Advanced Inpatient Management of Opioid Use Disorder in a Patient Requiring Serial Surgeries. J Gen Intern Med. 2021 08; 36(8):2448-2451. PMID: 33782885.
      View in: PubMed
    19. Terasaki D, Klie K. Tramadol Withdrawal in the Setting of Buprenorphine Induction: A Case Report. J Addict Med. 2020 May/Jun; 14(3):264-266. PMID: 31574012.
      View in: PubMed
    20. Terasaki D, Smith C, Calcaterra SL. Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol. Pharmacotherapy. 2019 10; 39(10):1023-1029. PMID: 31348544.
      View in: PubMed
    21. Terasaki D, Ornelas I, Saelens B. Length of Residence and Vehicle Ownership in Relation to Physical Activity Among U.S. Immigrants. J Immigr Minor Health. 2017 04; 19(2):484-488. PMID: 26868494.
      View in: PubMed
    22. Terasaki DJ, Gelaye B, Berhane Y, Williams MA. Anger expression, violent behavior, and symptoms of depression among male college students in Ethiopia. BMC Public Health. 2009 Jan 12; 9:13. PMID: 19138431.
      View in: PubMed
    Terasaki's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (69) concept(s)
    _
    Co-Authors Expand Description
    See all (8) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)